The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications / Podar, K; Zimmerhackl, A; Fulciniti, M; Tonon, G; Hainz, U; Tai, Yt; Vallet, S; Halama, N; Jäger, D; Olson, Dl; Sattler, M; Chauhan, D; Anderson, Kc.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - 155:(2011), pp. 438-448. [10.1111/j.1365-2141.2011.08864.x]
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications.
Tonon G;
2011-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
